• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证 QCOVID 风险预测算法在英国威尔士成年人群中 COVID-19 死亡率风险的预测能力。

Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK.

机构信息

Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea, SA2 8PP.

Health Analysis and Life Events Division, Office for National Statistics, NP10 8XG.

出版信息

Int J Popul Data Sci. 2022 Feb 15;5(4):1697. doi: 10.23889/ijpds.v5i4.1697. eCollection 2020.

DOI:10.23889/ijpds.v5i4.1697
Abstract

INTRODUCTION

COVID-19 risk prediction algorithms can be used to identify at-risk individuals from short-term serious adverse COVID-19 outcomes such as hospitalisation and death. It is important to validate these algorithms in different and diverse populations to help guide risk management decisions and target vaccination and treatment programs to the most vulnerable individuals in society.

OBJECTIVES

To validate externally the QCOVID risk prediction algorithm that predicts mortality outcomes from COVID-19 in the adult population of Wales, UK.

METHODS

We conducted a retrospective cohort study using routinely collected individual-level data held in the Secure Anonymised Information Linkage (SAIL) Databank. The cohort included individuals aged between 19 and 100 years, living in Wales on 24 January 2020, registered with a SAIL-providing general practice, and followed-up to death or study end (28 July 2020). Demographic, primary and secondary healthcare, and dispensing data were used to derive all the predictor variables used to develop the published QCOVID algorithm. Mortality data were used to define time to confirmed or suspected COVID-19 death. Performance metrics, including R values (explained variation), Brier scores, and measures of discrimination and calibration were calculated for two periods (24 January-30 April 2020 and 1 May-28 July 2020) to assess algorithm performance.

RESULTS

1,956,760 individuals were included. 1,192 (0.06%) and 610 (0.03%) COVID-19 deaths occurred in the first and second time periods, respectively. The algorithms fitted the Welsh data and population well, explaining 68.8% (95% CI: 66.9-70.4) of the variation in time to death, Harrell's C statistic: 0.929 (95% CI: 0.921-0.937) and D statistic: 3.036 (95% CI: 2.913-3.159) for males in the first period. Similar results were found for females and in the second time period for both sexes.

CONCLUSIONS

The QCOVID algorithm developed in England can be used for public health risk management for the adult Welsh population.

摘要

简介

COVID-19 风险预测算法可用于识别短期严重 COVID-19 结局(如住院和死亡)的高危个体。在不同和多样化的人群中验证这些算法非常重要,有助于指导风险管理决策,并将疫苗接种和治疗计划针对社会中最脆弱的个体。

目的

在英国威尔士的成年人群中,对预测 COVID-19 死亡率的 QCOVID 风险预测算法进行外部验证。

方法

我们进行了一项回顾性队列研究,使用 Secure Anonymised Information Linkage(SAIL)数据库中收集的个体水平常规数据。该队列包括年龄在 19 至 100 岁之间、2020 年 1 月 24 日居住在威尔士、注册了提供 SAIL 的全科医生、并随访至死亡或研究结束(2020 年 7 月 28 日)的个体。人口统计学、初级和二级医疗保健以及配药数据用于推导用于开发已发表的 QCOVID 算法的所有预测变量。死亡率数据用于确定确诊或疑似 COVID-19 死亡的时间。为两个时期(2020 年 1 月 24 日至 4 月 30 日和 5 月 1 日至 7 月 28 日)计算了性能指标,包括 R 值(解释的变化)、Brier 评分以及区分度和校准度的度量,以评估算法性能。

结果

纳入了 1956760 人。第一和第二个时期分别发生了 1192(0.06%)和 610(0.03%)例 COVID-19 死亡。该算法非常适合威尔士数据和人群,解释了死亡时间的 68.8%(95%CI:66.9-70.4),男性第一时期 Harrell's C 统计量为 0.929(95%CI:0.921-0.937),D 统计量为 3.036(95%CI:2.913-3.159)。在女性和两性的第二个时期也得到了类似的结果。

结论

在英格兰开发的 QCOVID 算法可用于威尔士成年人群的公共卫生风险管理。

相似文献

1
Validating the QCOVID risk prediction algorithm for risk of mortality from COVID-19 in the adult population in Wales, UK.验证 QCOVID 风险预测算法在英国威尔士成年人群中 COVID-19 死亡率风险的预测能力。
Int J Popul Data Sci. 2022 Feb 15;5(4):1697. doi: 10.23889/ijpds.v5i4.1697. eCollection 2020.
2
An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England.QCovid 风险预测算法对成年人 COVID-19 死亡率风险的外部验证:英格兰全国验证队列研究。
Lancet Digit Health. 2021 Jul;3(7):e425-e433. doi: 10.1016/S2589-7500(21)00080-7. Epub 2021 May 25.
3
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.成人因冠状病毒 19 住院和死亡风险的生存风险预测算法(QCOVID):全国推导和验证队列研究。
BMJ. 2020 Oct 20;371:m3731. doi: 10.1136/bmj.m3731.
4
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland.外部验证 QCovid 风险预测算法在成年人 COVID-19 住院和死亡风险中的应用:苏格兰全国验证队列研究。
Thorax. 2022 May;77(5):497-504. doi: 10.1136/thoraxjnl-2021-217580. Epub 2021 Nov 15.
5
An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK.QCOVID3 风险预测算法对 COVID-19 住院和死亡风险的外部验证:英国威尔士 166 万接种成年人的观察性、前瞻性队列研究。
PLoS One. 2023 May 18;18(5):e0285979. doi: 10.1371/journal.pone.0285979. eCollection 2023.
6
Common protocol for validation of the QCOVID algorithm across the four UK nations.四国民众共同采用的验证 QCOVID 算法的通用协议。
BMJ Open. 2022 Jun 14;12(6):e050994. doi: 10.1136/bmjopen-2021-050994.
7
External validation of the QCovid 2 and 3 risk prediction algorithms for risk of COVID-19 hospitalisation and mortality in adults: a national cohort study in Scotland.外部验证 QCovid 2 和 3 风险预测算法在成人 COVID-19 住院和死亡风险中的应用:苏格兰全国队列研究。
BMJ Open. 2023 Dec 27;13(12):e075958. doi: 10.1136/bmjopen-2023-075958.
8
Antipsychotic drug prescribing and mortality in people with dementia before and during the COVID-19 pandemic: a retrospective cohort study in Wales, UK.抗精神病药物处方与新冠大流行前后痴呆患者的死亡率:英国威尔士的一项回顾性队列研究。
Lancet Healthy Longev. 2023 Aug;4(8):e421-e430. doi: 10.1016/S2666-7568(23)00105-8.
9
Impact of the COVID-19 pandemic on domiciliary care workers in Wales, UK: a data linkage cohort study using the SAIL Databank.新冠疫情对英国威尔士居家护理工作者的影响:基于 SAIL 数据库的数据分析队列研究。
BMJ Open. 2023 Jun 1;13(6):e070637. doi: 10.1136/bmjopen-2022-070637.
10
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study.在威尔士,使用莫努匹拉韦、奈玛特韦-利托那韦和索特罗维单抗预防 COVID-19 高风险患者住院的真实世界效果:一项回顾性队列研究。
J Infect. 2023 Apr;86(4):352-360. doi: 10.1016/j.jinf.2023.02.012. Epub 2023 Feb 10.

引用本文的文献

1
Development and validation of a risk prediction model for hospital admission in COVID-19 patients presenting to primary care.开发和验证针对到基层医疗就诊的 COVID-19 患者的住院风险预测模型。
Eur J Gen Pract. 2024 Dec;30(1):2339488. doi: 10.1080/13814788.2024.2339488. Epub 2024 Apr 29.
2
Cardiac interventions in Wales: A comparison of benefits between NHS Wales specialties.威尔士的心脏介入治疗:NHS 威尔士各专业之间的效益比较。
PLoS One. 2024 Feb 9;19(2):e0297049. doi: 10.1371/journal.pone.0297049. eCollection 2024.
3
External validation of the QCovid 2 and 3 risk prediction algorithms for risk of COVID-19 hospitalisation and mortality in adults: a national cohort study in Scotland.

本文引用的文献

1
An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England.QCovid 风险预测算法对成年人 COVID-19 死亡率风险的外部验证:英格兰全国验证队列研究。
Lancet Digit Health. 2021 Jul;3(7):e425-e433. doi: 10.1016/S2589-7500(21)00080-7. Epub 2021 May 25.
2
Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.Fine-Gray 子分布风险模型可同时估计不同事件类型的绝对风险:累积总失效概率可能超过 1。
Stat Med. 2021 Aug 30;40(19):4200-4212. doi: 10.1002/sim.9023. Epub 2021 May 9.
3
外部验证 QCovid 2 和 3 风险预测算法在成人 COVID-19 住院和死亡风险中的应用:苏格兰全国队列研究。
BMJ Open. 2023 Dec 27;13(12):e075958. doi: 10.1136/bmjopen-2023-075958.
4
Vaccine effectiveness for prevention of covid-19 related hospital admission during pregnancy in England during the alpha and delta variant dominant periods of the SARS-CoV-2 pandemic: population based cohort study.在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行的阿尔法和德尔塔变异株主导时期,英格兰孕期预防新冠病毒病相关住院的疫苗有效性:基于人群的队列研究
BMJ Med. 2023 Jul 10;2(1):e000403. doi: 10.1136/bmjmed-2022-000403. eCollection 2023.
5
Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.英国在 COVID-19 大流行期间对临床脆弱人群实施屏蔽政策的理由:一项定性研究。
BMJ Open. 2023 Aug 4;13(8):e073464. doi: 10.1136/bmjopen-2023-073464.
6
Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.奥密克戎变异株流行期间英格兰 SARS-CoV-2 感染阳性成年人的新冠相关死亡或住院风险预测(QCOVID4):队列研究。
BMJ. 2023 Jun 21;381:e072976. doi: 10.1136/bmj-2022-072976.
7
An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK.QCOVID3 风险预测算法对 COVID-19 住院和死亡风险的外部验证:英国威尔士 166 万接种成年人的观察性、前瞻性队列研究。
PLoS One. 2023 May 18;18(5):e0285979. doi: 10.1371/journal.pone.0285979. eCollection 2023.
8
Prognostic models in COVID-19 infection that predict severity: a systematic review.COVID-19 感染中预测严重程度的预后模型:系统评价。
Eur J Epidemiol. 2023 Apr;38(4):355-372. doi: 10.1007/s10654-023-00973-x. Epub 2023 Feb 25.
9
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration.协调电子健康记录以实现可重复研究:来自英国 COVID-19 研究合作的挑战、解决方案和建议。
BMC Med Inform Decis Mak. 2023 Jan 16;23(1):8. doi: 10.1186/s12911-022-02093-0.
10
Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study.疫苗接种阶段英格兰大流行第二波和第三波期间 COVID-19 死亡率的种族差异:一项回顾性、基于人群的队列研究。
BMC Med. 2023 Jan 8;21(1):13. doi: 10.1186/s12916-022-02704-7.
Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventions.
理解和应对威尔士的 COVID-19 :一个隐私保护数据平台,用于增强流行病学和干预措施评估的方案。
BMJ Open. 2020 Oct 21;10(10):e043010. doi: 10.1136/bmjopen-2020-043010.
4
Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.成人因冠状病毒 19 住院和死亡风险的生存风险预测算法(QCOVID):全国推导和验证队列研究。
BMJ. 2020 Oct 20;371:m3731. doi: 10.1136/bmj.m3731.
5
The impact of COVID-19 on adjusted mortality risk in care homes for older adults in Wales, UK: a retrospective population-based cohort study for mortality in 2016-2020.新冠疫情对英国威尔士老年人护理院调整后死亡率的影响:2016-2020 年死亡率的回顾性基于人群队列研究。
Age Ageing. 2021 Jan 8;50(1):25-31. doi: 10.1093/ageing/afaa207.
6
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.美国 31461 例 COVID-19 成年人死亡相关合并症:一项联合电子病历分析。
PLoS Med. 2020 Sep 10;17(9):e1003321. doi: 10.1371/journal.pmed.1003321. eCollection 2020 Sep.
7
Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.COVID-19 患者合并症的患病率及其与死亡率的关系:系统评价和荟萃分析。
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924. doi: 10.1111/dom.14124. Epub 2020 Jul 16.
8
Shielding from covid-19 should be stratified by risk.对新冠病毒的防护应按风险分层。
BMJ. 2020 May 28;369:m2063. doi: 10.1136/bmj.m2063.
9
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.使用 ISARIC WHO 临床特征协议住院的 20133 例英国新冠患者的特征:前瞻性观察队列研究。
BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985.
10
Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.肥胖是重症 COVID-19 感染的危险因素:多种潜在机制。
Circulation. 2020 Jul 7;142(1):4-6. doi: 10.1161/CIRCULATIONAHA.120.047659. Epub 2020 Apr 22.